Search research articles
Contact Us
Filters
Showing results (51-60 of 80) with videos related to
Page
of 8
Sort By:
Nature Medicine
|
June 3, 2020
Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosis
Priscilla K Brastianos, Eudocia Quant Lee, Justine V Cohen, et al.
Acta Neuropathologica Communications
|
January 16, 2015
Sporadic hemangioblastomas are characterized by cryptic VHL inactivation
Ganesh M Shankar, Amaro Taylor-Weiner, Nina Lelic, et al.
Cancer Discovery
|
September 5, 2014
The genomic landscape of pediatric Ewing sarcoma
Brian D Crompton, Chip Stewart, Amaro Taylor-Weiner, et al.
Nature Medicine
|
May 20, 2014
Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine
Eliezer M Van Allen, Nikhil Wagle, Petar Stojanov, et al.
Nature Genetics
|
March 26, 2013
Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity
Austin M Dulak, Petar Stojanov, Shouyong Peng, et al.
Genome Biology
|
July 7, 2007
Transcriptional recapitulation and subversion of embryonic colon development by mouse colon tumor models and human colon cancer
Sergio Kaiser, Young-Kyu Park, Jeffrey L Franklin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 11, 2013
Integrative and comparative genomic analysis of lung squamous cell carcinomas in East Asian patients
Youngwook Kim, Peter S Hammerman, Jaegil Kim, et al.
Cell
|
May 11, 2015
Prospective derivation of a living organoid biobank of colorectal cancer patients
Marc van de Wetering, Hayley E Francies, Joshua M Francis, et al.
Nature Communications
|
May 21, 2016
Clonal evolution in patients with chronic lymphocytic leukaemia developing resistance to BTK inhibition
Jan A Burger, Dan A Landau, Amaro Taylor-Weiner, et al.
Acta Neuropathologica
|
August 21, 2018
DMD genomic deletions characterize a subset of progressive/higher-grade meningiomas with poor outcome
Tareq A Juratli, Devin McCabe, Naema Nayyar, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 80) with videos related to
Sort By:
Page
of 8
Nature Medicine
|
June 3, 2020
Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosis
Priscilla K Brastianos, Eudocia Quant Lee, Justine V Cohen, et al.
Acta Neuropathologica Communications
|
January 16, 2015
Sporadic hemangioblastomas are characterized by cryptic VHL inactivation
Ganesh M Shankar, Amaro Taylor-Weiner, Nina Lelic, et al.
Cancer Discovery
|
September 5, 2014
The genomic landscape of pediatric Ewing sarcoma
Brian D Crompton, Chip Stewart, Amaro Taylor-Weiner, et al.
Nature Medicine
|
May 20, 2014
Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine
Eliezer M Van Allen, Nikhil Wagle, Petar Stojanov, et al.
Nature Genetics
|
March 26, 2013
Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity
Austin M Dulak, Petar Stojanov, Shouyong Peng, et al.
Genome Biology
|
July 7, 2007
Transcriptional recapitulation and subversion of embryonic colon development by mouse colon tumor models and human colon cancer
Sergio Kaiser, Young-Kyu Park, Jeffrey L Franklin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 11, 2013
Integrative and comparative genomic analysis of lung squamous cell carcinomas in East Asian patients
Youngwook Kim, Peter S Hammerman, Jaegil Kim, et al.
Cell
|
May 11, 2015
Prospective derivation of a living organoid biobank of colorectal cancer patients
Marc van de Wetering, Hayley E Francies, Joshua M Francis, et al.
Nature Communications
|
May 21, 2016
Clonal evolution in patients with chronic lymphocytic leukaemia developing resistance to BTK inhibition
Jan A Burger, Dan A Landau, Amaro Taylor-Weiner, et al.
Acta Neuropathologica
|
August 21, 2018
DMD genomic deletions characterize a subset of progressive/higher-grade meningiomas with poor outcome
Tareq A Juratli, Devin McCabe, Naema Nayyar, et al.
Page
of 8